Drug Discovery

Is GAL-101 the Future of AMD Treatment?
Research & Development Is GAL-101 the Future of AMD Treatment?

The world of ophthalmology faces a promising yet complex challenge as it navigates the treatment of age-related macular degeneration (AMD), a leading cause of vision loss across the globe. In recent years, advancements in medical research have unveiled new pathways to tackle this degenerative

Will Aumseqa Revolutionize NSCLC Treatment with EGFR Mutation?
Management & Regulatory Will Aumseqa Revolutionize NSCLC Treatment with EGFR Mutation?

In the rapidly evolving landscape of cancer treatments, Aumseqa (aumolertinib) has emerged as a promising advancement against non-small cell lung cancer (NSCLC) characterized by EGFR mutations. Recently approved by the Medicines and Healthcare products Regulatory Agency (MHRA), Aumseqa is

LabGenius Welcomes Dr. Sinclair as New CSO to Drive Antibody Innovation
Tech & Innovation LabGenius Welcomes Dr. Sinclair as New CSO to Drive Antibody Innovation

How does a single leadership appointment hold the potential to change the trajectory of cancer drug discovery? The appointment of Dr. Angus Sinclair as the Chief Scientific Officer at LabGenius is poised to redefine the future of therapeutic antibodies, with implications that could resonate

EU Regulations Transform Clinical Trials with AI and Data Integration
Management & Regulatory EU Regulations Transform Clinical Trials with AI and Data Integration

Recent European Union regulations have significantly reshaped the clinical trials landscape, positioning compliance as a competitive advantage for biopharmaceutical firms. With frameworks such as the EU General Data Protection Regulation (GDPR), the Artificial Intelligence (AI) Act, and the

Neurology's 2025 Leap: Neuroprotection and Patient-Centric Care
Research & Development Neurology's 2025 Leap: Neuroprotection and Patient-Centric Care

The landscape of neurology is undergoing a seismic shift as new advancements in research and treatment redefine approaches to longstanding neurological diseases. Historically, the focus has been on managing symptoms, often overlooking deeper disease mechanisms and progression. Today, this is

Can Diabetes Treatment Revolutionize Vision Loss Prevention?
Research & Development Can Diabetes Treatment Revolutionize Vision Loss Prevention?

The urgent need for innovative treatments in diabetic retinopathy, a primary cause of blindness among working-age adults worldwide, captures significant attention. With both type 1 and type 2 diabetes contributing to the condition, diabetic retinopathy occurs due to the deterioration of blood

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later